Drug Database
Back to search

Netherlands· NL-6fe6a675c3bc

Daraprim 25 mg tabletten

A pyrimethamine product containing pyrimethamine, registered in Netherlands by GlaxoSmithKline B.V.. The same ATC class is registered in 9 of our 19 countries.

ATC P01BD01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedDaraprim 25 mg tablettenATCP01BD01REGISTER NO.NL-6fe6a675c3bcPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pyrimethamineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pyrimethamine is registered in 9 of 19 countries.

Countries holding a registration under ATC P01BD01 (pyrimethamine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search pyrimethamine products by name

Pyrimethamine · ATC P01BD01

9 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Franceprice
  • Germany
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pyrimethamine costs, country by country.

Normalised to the WHO defined daily dose (75 mg), the median price runs from $0.97 in France to $3.75 in Switzerland — a ×3.9 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Pyrimethamine · price per daily dose (75 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.75
  • FR France$0.97
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
PYRIMETHAMINE
Manufacturer
GlaxoSmithKline B.V.
Country
Netherlands (NL)
ATC code
P01BD01
ATC class
Pyrimethamine
Defined daily dose
75 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    00254

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

48 interactions on record for pyrimethamine.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pyrimethamine against other medicinesHow interaction checks work

Pyrimethamine · interactions on record

48 records

  • 4 severe
  • 28 moderate
  • 2 minor
  • 14 info

Most severe, free to view

  • Sodium aurothiomalateM01CB01severe
  • AuranofinM01CB03severe
  • AurothioglucoseM01CB04severe
  • DeferiproneV03AC02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pyrimethamine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pyrimethamine products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Belgium · Daraprim
  • Germany · Daraprim
  • Spain · Daraprim
  • United Kingdom (Northern Ireland) · Daraprim
  • Luxembourg · Daraprim
  • Portugal · Pirimetamina Labesfal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/972016f4-bfea-49e5-9973-7ba07808124a
GET /v1/drugs/972016f4-bfea-49e5-9973-7ba07808124a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h00254_smpc.pdf",
  "strength": null,
  "atc_label": "Pyrimethamine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg00254",
  "excipients": [
    "DOCUSAATNATRIUM",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "STARCH,  HYDROLYSED"
  ],
  "substances": [
    "PYRIMETHAMINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h00254.pdf",
  "authorised_at": "1990/05/20",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "00254",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about pyrimethamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console